Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
- PMID: 28589404
- PMCID: PMC5504197
- DOI: 10.1007/s12325-017-0563-2
Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
Erratum for
-
Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials.Adv Ther. 2017 Jun;34(6):1327-1339. doi: 10.1007/s12325-017-0521-z. Epub 2017 Apr 10. Adv Ther. 2017. PMID: 28397079 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
